Allogene Therapeutics, Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Collaboration Agreements (6 contracts)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Settlement Agreements (1)
- Amendment No. 1 to Amended and Restated Collaboration and License Agreement, dated May 17, 2024, by and between Allogene Therapeutics, Inc. and Notch Therapeutics (Canada) Inc (Filed With SEC on August 7, 2024)
- Amendment and Settlement Agreement, dated May 10, 2024, by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier and Allogene Therapeutics, Inc (Filed With SEC on August 7, 2024)
- Strategic Collaboration Agreement, dated January 3, 2024, by and between Foresight Diagnostics, Inc. and the Registrant (Filed With SEC on March 14, 2024)
- Amended and Restated Collaboration and License Agreement, dated January 17, 2024, by and between the Registrant and Notch Therapeutics Inc (Filed With SEC on March 14, 2024)
- Amendment No. 2 to Sales Agreement, dated November 2, 2023, by and between the Registrant and Cowen and Company, LLC (Filed With SEC on November 2, 2023)
- Collaboration and License Agreement, dated November 1, 2019, by and between the Registrant and Notch Therapeutics Inc (Filed With SEC on February 27, 2020)
- Indemnification Agreement, dated April 6, 2018, by and between the Registrant and John DeYoung (Filed With SEC on October 2, 2018)
- Exclusive License and Collaboration Agreement, dated October 30, 2015, by and between the Registrant (assignee of Pfizer Inc.) and Les Laboratoires Servier and Institut de... (Filed With SEC on September 17, 2018)
- Research Collaboration and License Agreement, dated June 17, 2014, by and between the Registrant (assignee of Pfizer Inc.) and Cellectis SA, as amended (Filed With SEC on September 14, 2018)
